Lipoprotein metabolism and lipid management in chronic kidney disease

J Am Soc Nephrol. 2007 Apr;18(4):1246-61. doi: 10.1681/ASN.2006091006. Epub 2007 Mar 14.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Antioxidants / therapeutic use
  • Cardiovascular Diseases / etiology
  • Chronic Disease
  • Dyslipidemias / drug therapy*
  • Dyslipidemias / etiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Kidney Diseases / complications
  • Kidney Diseases / metabolism*
  • Lipoproteins / chemistry
  • Lipoproteins / metabolism*
  • Niacin / therapeutic use
  • Renal Dialysis

Substances

  • Antioxidants
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipoproteins
  • Niacin